Beneficial effects of statin therapy on survival in hypertensive patients with acute myocardial infarction: Aata from the RICO survey

被引:8
作者
Sicard, Pierre
Zeller, Marianne
Dentan, Gilles
Laurent, Yves
Touzery, Claude
L'huillier, Isabelle
Janin-Manificat, Luc
Lorgis, Luc
Beer, Jean-Claude
Makki, Hamib
Rochette, Luc
Cottin, Yves
机构
[1] Fac Med & Pharm Dijon, Lab Physiopathol & Pharmacol Cardio Vasc Expt, IFR Sante STIC, F-21000 Dijon, France
[2] CHU Dijon, Serv Cardiol, Dijon, France
[3] Clin Fontaine, Serv Cardiol, Dijon, France
[4] Clin Fontaine, Serv Cardiol, Semur En Auxois, France
[5] CH Semur En Auxois, Serv Cardiol, Semur En Auxois, France
[6] CH Beaune, Serv Cardiol, Beaune, France
[7] CH Chatillon Sur Seine, Serv Cardiol, Chatillon Sur Seine, France
关键词
hypertension; acute myocardial infarction; statin; cohort study; ACUTE CORONARY SYNDROMES; RANDOMIZED CONTROLLED-TRIAL; LOWERING TREATMENT; CHOLESTEROL LEVELS; HEART-DISEASE; OUTCOMES; EVENTS; PRAVASTATIN; PREVENTION; INITIATION;
D O I
10.1016/j.amjhyper.2007.05.006
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Randomized studies have shown a reduction in cardiovascular events associated with low doses of statin among hypertensive patients at only moderate cardiovascular risk. The hypothesis of the present study was that statin therapy initiated during hospitalization could improve the long-term outcome after acute myocardial infarction (MI) in hypertensive patients. Methods: From the French regional obserRvatoire des Infarctus de Cote d'Or (RICO) survey, 1076 patients with a history of hypertension, surviving acute MI were included. Patients on statin therapy initiated before their hospitalization were excluded from the study. Patients were categorized into two groups based on whether or not statin treatment was initiated during the hospital stay. Results: Patients in the statin group were younger (70 years [range, 58 to 77 years] nu 75 years [range, 65 to 82 years], P < .001) and were more likely to have hypercholesterolemia (42% nu 28 %, P < .001). No differences were observed between the two groups for LDL-cholesterol levels on admission. At 1-year follow-up, cardiovascular mortality and rehospitalization for heart failure were lower in the statin group (respectively, 5% nu 15%, P < .001; 5% nu 7%, P < .001). Multivariate analysis showed that statin therapy was associated with decreased mortality (hazard ratio [95% confidence interval; CI]: 0.58 [0.32-0.98], P = .035) independently of either hypercholesterolemia, the use of beta-blockers, angiotensin-converting enzyme inhibitors, or diuretics, but not with a decreased incidence of heart failure (hazard ratio [95% CI]: 0.88 [0.55-1.23], P = .152). Conclusions: In this observational study, the long-term benefits of statin therapy initiated in-hospital in hypertensive patients after acute MI was demonstrated. These findings may have implications for treatment optimization of hypertensive patients in secondary prevention. (C) 2007 American Journal of Hypertension, Ltd.
引用
收藏
页码:1133 / 1139
页数:7
相关论文
共 28 条
[1]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[2]   In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization - A propensity analysis [J].
Aronow, HD ;
Novaro, GM ;
Lauer, MS ;
Brennan, DM ;
Lincoff, AM ;
Topol, EJ ;
Kereiakes, DJ ;
Nissen, SE .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (21) :2576-2582
[3]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[4]   The pleiotropic effects of statins [J].
Calabrò, P ;
Yeh, ETH .
CURRENT OPINION IN CARDIOLOGY, 2005, 20 (06) :541-546
[5]   Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[6]   Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty:: results from the nationwide French PREVENIR survey [J].
Danchin, N ;
Grenier, O ;
Ferrières, J ;
Cantet, C ;
Cambou, JP .
HEART, 2002, 88 (02) :159-162
[7]   Beneficial cardiovascular pleiotropic effects of statins [J].
Davignon, J .
CIRCULATION, 2004, 109 (23) :39-43
[8]  
Dumaine Raphaelle, 2006, J Clin Hypertens (Greenwich), V8, P315, DOI 10.1111/j.1524-6175.2006.05384.x
[9]   Effect of early initiation of statins on survival in patients with acute myocardial infarction (the USIC 5000 registry) [J].
Ferrières, J ;
Cambou, JP ;
Guéret, P ;
Boutalbi, Y ;
Lablanche, JM ;
Hanania, G ;
Genès, N ;
Cantet, C ;
Danchin, N .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (04) :486-489
[10]   Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality [J].
Fonarow, GC ;
Wright, RS ;
Spencer, FA ;
Fredrick, PD ;
Dong, W ;
Every, N ;
French, WJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (05) :611-616